898235

GlaxoSmithKline LLC — FEI 1035048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 29, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)